跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LENALIDOMIDA KERN PHARMA 2,5 MG CAPSULAS DURAS EFG
Approved
STANDARD
LENALIDOMIDA KERN PHARMA 2,5 MG CAPSULAS DURAS EFG
Kern Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Sep 30, 2020
Approval ID
0fdfeac7a9370f59
Company
Kern Pharma S.L.
Type
Standard
Approval Details
Approval Id
0fdfeac7a9370f59
Drug Cima Aemps Name
LENALIDOMIDA KERN PHARMA 2,5 MG CAPSULAS DURAS EFG
Register Number
85454
Holder Company Name
Kern Pharma S.L.
Marketing Company Name
Kern Pharma S.L.
Holder Company Detail Path
/organization/kern-pharma-s-l
Marketing Company Detail Path
/organization/kern-pharma-s-l
Authorization Date
2020-09-30
Dosage Form
CÁPSULA DURA
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
Yes
Company Name
Kern Pharma S.L.
Company Detail Path
/organization/kern-pharma-s-l
Company Information
Pharmaceutical Company Name
Kern Pharma S.L.
Country Name
Dominican Republic
Active Ingredients
LENALIDOMIDA
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Sep 30, 2020
Approval ID
0fdfeac7a9370f59
Type
Standard
Back to CIMA-AEMPS Approvals
LENALIDOMIDA KERN PHARMA 2,5 MG CAPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
